IBDEI14R ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18877,0)
 ;;=C81.90^^94^916^87
 ;;^UTILITY(U,$J,358.3,18877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18877,1,3,0)
 ;;=3^Hodgkin Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,18877,1,4,0)
 ;;=4^C81.90
 ;;^UTILITY(U,$J,358.3,18877,2)
 ;;=^5001451
 ;;^UTILITY(U,$J,358.3,18878,0)
 ;;=D89.2^^94^916^88
 ;;^UTILITY(U,$J,358.3,18878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18878,1,3,0)
 ;;=3^Hypergammaglobulenemia,Unspec
 ;;^UTILITY(U,$J,358.3,18878,1,4,0)
 ;;=4^D89.2
 ;;^UTILITY(U,$J,358.3,18878,2)
 ;;=^5002455
 ;;^UTILITY(U,$J,358.3,18879,0)
 ;;=D05.12^^94^916^89
 ;;^UTILITY(U,$J,358.3,18879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18879,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,18879,1,4,0)
 ;;=4^D05.12
 ;;^UTILITY(U,$J,358.3,18879,2)
 ;;=^5001931
 ;;^UTILITY(U,$J,358.3,18880,0)
 ;;=D05.11^^94^916^90
 ;;^UTILITY(U,$J,358.3,18880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18880,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,18880,1,4,0)
 ;;=4^D05.11
 ;;^UTILITY(U,$J,358.3,18880,2)
 ;;=^5001930
 ;;^UTILITY(U,$J,358.3,18881,0)
 ;;=D05.10^^94^916^91
 ;;^UTILITY(U,$J,358.3,18881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18881,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,18881,1,4,0)
 ;;=4^D05.10
 ;;^UTILITY(U,$J,358.3,18881,2)
 ;;=^5001929
 ;;^UTILITY(U,$J,358.3,18882,0)
 ;;=D50.0^^94^916^92
 ;;^UTILITY(U,$J,358.3,18882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18882,1,3,0)
 ;;=3^Iron Deficiency Anemia Secondary to Blood Loss
 ;;^UTILITY(U,$J,358.3,18882,1,4,0)
 ;;=4^D50.0
 ;;^UTILITY(U,$J,358.3,18882,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,18883,0)
 ;;=D50.9^^94^916^93
 ;;^UTILITY(U,$J,358.3,18883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18883,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,18883,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,18883,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,18884,0)
 ;;=C46.9^^94^916^94
 ;;^UTILITY(U,$J,358.3,18884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18884,1,3,0)
 ;;=3^Kaposi's Sarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,18884,1,4,0)
 ;;=4^C46.9
 ;;^UTILITY(U,$J,358.3,18884,2)
 ;;=^5001108
 ;;^UTILITY(U,$J,358.3,18885,0)
 ;;=C22.0^^94^916^95
 ;;^UTILITY(U,$J,358.3,18885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18885,1,3,0)
 ;;=3^Liver Cell Carcinoma
 ;;^UTILITY(U,$J,358.3,18885,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,18885,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,18886,0)
 ;;=D05.02^^94^916^96
 ;;^UTILITY(U,$J,358.3,18886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18886,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,18886,1,4,0)
 ;;=4^D05.02
 ;;^UTILITY(U,$J,358.3,18886,2)
 ;;=^5001928
 ;;^UTILITY(U,$J,358.3,18887,0)
 ;;=D05.01^^94^916^97
 ;;^UTILITY(U,$J,358.3,18887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18887,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,18887,1,4,0)
 ;;=4^D05.01
 ;;^UTILITY(U,$J,358.3,18887,2)
 ;;=^5001927
 ;;^UTILITY(U,$J,358.3,18888,0)
 ;;=D05.00^^94^916^98
 ;;^UTILITY(U,$J,358.3,18888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18888,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,18888,1,4,0)
 ;;=4^D05.00
 ;;^UTILITY(U,$J,358.3,18888,2)
 ;;=^5001926
 ;;^UTILITY(U,$J,358.3,18889,0)
 ;;=R59.0^^94^916^59
 ;;^UTILITY(U,$J,358.3,18889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18889,1,3,0)
 ;;=3^Enlarged Lymph Nodes,Localized
 ;;^UTILITY(U,$J,358.3,18889,1,4,0)
 ;;=4^R59.0
 ;;^UTILITY(U,$J,358.3,18889,2)
 ;;=^5019529
